Liquidia Corp. (LQDA)
42.65
+2.96
(+7.46%)
USD |
NASDAQ |
Oct 23, 16:00
42.25
-0.40
(-0.94%)
After-Hours: 20:00
Liquidia Market Cap : 3.800B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 3.800B |
| October 22, 2026 | 3.536B |
| October 21, 2026 | 3.462B |
| October 20, 2026 | 3.239B |
| October 19, 2026 | 3.041B |
| October 16, 2026 | 3.061B |
| October 15, 2026 | 3.099B |
| October 14, 2026 | 3.024B |
| October 13, 2026 | 2.389B |
| October 12, 2026 | 2.465B |
| October 09, 2026 | 2.440B |
| October 08, 2026 | 2.497B |
| October 07, 2026 | 2.377B |
| October 06, 2026 | 2.309B |
| October 05, 2026 | 2.463B |
| October 02, 2026 | 2.552B |
| October 01, 2026 | 2.494B |
| September 30, 2026 | 2.696B |
| September 29, 2026 | 6.298B |
| September 28, 2026 | 6.564B |
| September 25, 2026 | 6.097B |
| September 24, 2026 | 6.322B |
| September 23, 2026 | 6.013B |
| September 22, 2026 | 6.116B |
| September 21, 2026 | 5.919B |
| Date | Value |
|---|---|
| September 18, 2026 | 5.959B |
| September 17, 2026 | 6.094B |
| September 16, 2026 | 6.099B |
| September 15, 2026 | 5.856B |
| September 14, 2026 | 5.819B |
| September 11, 2026 | 5.947B |
| September 10, 2026 | 6.045B |
| September 09, 2026 | 6.159B |
| September 08, 2026 | 6.030B |
| September 04, 2026 | 6.118B |
| September 03, 2026 | 6.115B |
| September 02, 2026 | 6.208B |
| September 01, 2026 | 5.962B |
| August 31, 2026 | 6.074B |
| August 28, 2026 | 6.031B |
| August 27, 2026 | 6.232B |
| August 26, 2026 | 6.358B |
| August 25, 2026 | 6.281B |
| August 24, 2026 | 6.261B |
| August 21, 2026 | 6.114B |
| August 20, 2026 | 6.331B |
| August 19, 2026 | 6.712B |
| August 18, 2026 | 6.623B |
| August 17, 2026 | 6.923B |
| August 14, 2026 | 6.633B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Harmony Biosciences Holdings, Inc. | 2.100B |
| United Therapeutics Corp. | 25.07B |
| Johnson & Johnson | 635.02B |
| Amneal Pharmaceuticals, Inc. | 6.508B |
| Pfizer Inc. | 171.14B |
Market Cap Related Metrics
| PE Ratio | 31.26 |
| PS Ratio | 9.196 |
| Price to Book Value | 19.48 |
| Price to Free Cash Flow | 27.52 |
| Price | 42.65 |
| Earnings Yield | 3.20% |
| Operating PE Ratio | 24.60 |
| Normalized PE Ratio | 31.26 |